Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $25.23 in the prior trading day, Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) closed at $23.52, down -6.78%. In other words, the price has decreased by -$6.78 from its previous closing price. On the day, 0.84 million shares were traded. AMPH stock price reached its highest trading level at $25.0 during the session, while it also had its lowest trading level at $22.735.
Ratios:
Our goal is to gain a better understanding of AMPH by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.00 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.50. For the most recent quarter (mrq), Quick Ratio is recorded 2.19 and its Current Ratio is at 3.07. In the meantime, Its Debt-to-Equity ratio is 0.89 whereas as Long-Term Debt/Eq ratio is at 0.88.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on February 04, 2025, Downgraded its rating to Neutral and sets its target price to $36 from $66 previously.
On November 22, 2024, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $55.
On March 05, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $60.JP Morgan initiated its Overweight rating on March 05, 2024, with a $60 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 01 ’25 when Petersen Floyd F. sold 500 shares for $28.38 per share. The transaction valued at 14,190 led to the insider holds 73,909 shares of the business.
Petersen Floyd F. bought 500 shares of AMPH for $14,430 on Apr 01 ’25. On Mar 06 ’25, another insider, Petersen Floyd F., who serves as the Director of the company, sold 1,000 shares for $27.99 each. As a result, the insider received 27,986 and left with 74,409 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMPH now has a Market Capitalization of 1202213120 and an Enterprise Value of 1696873728. As of this moment, Amphastar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.68, and their Forward P/E ratio for the next fiscal year is 6.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.53 while its Price-to-Book (P/B) ratio in mrq is 1.53. Its current Enterprise Value per Revenue stands at 2.318 whereas that against EBITDA is 6.567.
Stock Price History:
The Beta on a monthly basis for AMPH is 0.79, which has changed by -0.40636045 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, AMPH has reached a high of $53.96, while it has fallen to a 52-week low of $23.36. The 50-Day Moving Average of the stock is -19.87%, while the 200-Day Moving Average is calculated to be -41.35%.
Shares Statistics:
The stock has traded on average 610.01K shares per day over the past 3-months and 785790 shares per day over the last 10 days, according to various share statistics. A total of 47.62M shares are outstanding, with a floating share count of 35.19M. Insiders hold about 26.15% of the company’s shares, while institutions hold 74.96% stake in the company. Shares short for AMPH as of 1741910400 were 3852850 with a Short Ratio of 5.61, compared to 1739491200 on 4072042. Therefore, it implies a Short% of Shares Outstanding of 3852850 and a Short% of Float of 12.49.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
